Active Motif Announces Exclusive Global Distribution Agreement with Arima Genomics for Advanced 3D Genomics Solutions
Agreement expands Active Motif’s research genomics portfolio while supporting Arima’s strategic focus on its clinical diagnostics platform CARLSBAD, Calif., July 6, 2026 /PRNewswire/ — Active Motif, a leading provider of epigenetics and multiomic
